InvestorsHub Logo
icon url

uksausage

03/19/12 10:40 AM

#20126 RE: Simpsonly #20124

2009 was an interesting year for BIEL.
the 0.12 hit was as a result of Joe Noel being used to "pump
the stock" partly so they could retire debt. It was all on the back of filling 501k applications for Actipatch which we now know they fully expected to be rejected and have to start the De Novo process (2yrs). Had we known that then......

Mr Whelan also mentioned in an internet radio interview I think that he had turned down an offer of 0.20c for the company as it wasn't insane enough

I suspect of that offer was made again before approval he might take it, it would certainly be a good starting point for offers on approval.

I do not know why companies aren't taking positions here as they would either then have a good starting point for buy out or at least profit from a sale elsewhere. Chances of FDA turning down the application are slight and the international market if backed by suitable finance would be great anyway.